Aayush Wellness has received Board of Directors’ approval for formation of a wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000. This strategic expansion marks a significant step in the company’s global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets.
Key focus areas of the subsidiary are localizing product offerings to align with regulatory and cultural preferences, forging strategic partnerships and e-commerce distribution channels across ASEAN, driving export growth from India while expanding the company’s international brand presence, establishing a regional R&D and innovation hub to adapt to market-specific wellness trends.
Aayush Wellness is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: